| Literature DB >> 33376424 |
Tsegahun Asfaw1, Deribew Genetu1, Demissew Shenkute1.
Abstract
BACKGROUND: Currently, antibiotic-resistant bacteria (ARB) have become a serious global problem and considered as One Health challenge. Despite, wastewater contains a wide range of microbial pathogens and plays a significant role in the dissemination of ARB in the environment. However, it is the most overlooked in developing countries, particularly in Ethiopia.Entities:
Keywords: Ethiopia; antibiotic resistance; antibiotic-resistant bacteria; wastewater
Year: 2020 PMID: 33376424 PMCID: PMC7755345 DOI: 10.2147/RMHP.S277640
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1Flow chart of selections of studies that assessed ARB in wastewater released to the environment in Ethiopia.
Description of Relevant Studies Included in Systematic Review
| ID | Reference | Study Area | Source of Sample and Year of Sampling | Sampling Point | Study Objective | Key Findings | Recommendation |
|---|---|---|---|---|---|---|---|
| 1 | S. dires et al 2018 | Hawassa University, Southern Ethiopia | Hospital Wastewater | Inlet and Outlets of temporary collection tank | Effectiveness in the removal of ARB from hospital wastewater | Indicator organism, ARB and MDR bacteria in treated wastewater | Constructed wetland Could be promoted |
| 2 | Fekadu et al 2015 | Yirgalem and Hawassa, Southern Ethiopia | Hospital wastewater | Inlet and Outlets of Pretreated septic tank (Yirgalem) Oxidation pond system (Hawassa) | Assessment of antibiotic and disinfectant resistant bacteria | Indicator organism, Pathogenic and ARB bacteria in the final effluent of wastewater | Proper wastewater treatment before released to receiving environment |
| 3 | Moges et al 2014 | Gondar, Northwest Ethiopia | Hospital wastewater and Nonhospital Environment | Superficial wastewater and a different outlet from different section of the hospital and Superficial wastewater from different nonhospital institutions | Isolate and characterize public health important bacteria | MDR bacteria in wastewater and high prevalence in hospital wastewater | Proper wastewater treatment plant should be established and improved sanitary measure should be practice. |
| 4 | Engda et al 2018 | Gondar, Northwest Ethiopia | Hospital Environment and Wastewater | Surface of bed frames, bedside tables, door handle, floors, sinks, waiting chairs and walls of different wards and hospital sewerage system | Magnitude, distribution, and antimicrobial susceptibility of ESBL producing | High prevalence of MDR bacteria to the commonly used Antibiotics | Hospital should install proper hygiene and rational use of antimicrobials. |
| 5 | Belachew et al 2018 | Addis Ababa, Ethiopia | Sewage Polluted Urban Rivers,2017 | Downstream of Rivers | Determine the level of drug resistance of gram-negative bacteria | Medically important gram-negative bacteria with a high degree of MDR | Not stated or No recommendations |
| 6 | Tesfaye et al 2019 | Addis Ababa, Ethiopia | Health facilities, abattoir, Rivers and WWTP.2017 | Hospital sewerage system, Downstream revers and WWTP | Antimicrobial susceptibility of | ARB and MDR bacteria in Hospital wastewater, Downstream revers and WWTP | Hospitals and abattoir |
| 7 | T. Asfaw et al 2017 | Mekelle, North Ethiopia | Hospital Wastewater | Inlet and Outlets of Oxidation pond system | Prevalence and drug resistance of bacterial pathogen | Indicator organism, ARB and MDR bacteria in treated wastewater | Liquid waste treatment system (Chlorination) should be developed |
Type of Bacteria Isolated, Antibiotic Used and Drug Resistance Patterns for Studies Included in Systematic Review
| ID | Reference | Type of Bacteria Isolated | Antibiotic Tested Against Isolates | Drug Resistance Pattern |
|---|---|---|---|---|
| 1 | S. Dires et al 2018 | Ciprofloxacin, Ceftriaxone, Ceftazidime, Cotrimoxazole, Erythromycin, Nalidixic Acid, Doxycycline, Amoxicillin-clavulanic, Cefoxitin, Gentamicin and Chloramphenicol | The overall MDR prevalence in the final wastewater was 34.2%, where | |
| 2 | Fekadu et al 2015 | Gentamycin, Erythromycin, Penicillin, Amoxicillin, Ampicillin, Ciprofloxacin, Erythromycin, Tetracycline, Ceftriaxone and | E. coli, Salmonella and | |
| 3 | Moges et al 2014 | Ampicillin, Chloramphenicol, Ciprofloxacin, Clindamycin, Erythromycin, Gentamicin, Methicillin, Vancomycin, Streptomycin, Trimethoprim-Sulfamethoxazole, Tetracycline, Nalidixic Acid, Cephalothin, Cefotaxime, Kanamycin | The overall MDR prevalence was 69.9% where 54.2% in the non-hospital environment and 81.5% from the hospital environment. | |
| 4 | Engda et al 2018 | Beta-lactam and non-beta-lactam antimicrobials | 56% of ESBL producing Enterobacteriaceae were MDR for non-beta-lactam antibiotics. All ESBL producing | |
| 5 | Belachew et al 2018 | Ampicillin, Cefazolin, Amoxicillin/Clavulanic acid, Piperacillin/Tazobactam, Cephalothin, Cefuroxime, Cefuroxime, Cefoxitin, Cefpodoxime, Ceftazidime, Ceftriaxone, Cefepime, Gentamicin, Tobramycin, Ciprofloxacin, Levofloxacin, Tetracycline, Nitrofurantoin, Trimethoprim/sulfamethoxazole | The overall MDR prevalence was 64%. | |
| 6 | Tesfaye et al 2019 | Amoxicillin + Clavulanic acid, Ciprofloxacin, Gentamicin, Sulfamethoxazole + Trimethoprim, Trimethoprim, Tetracycline, Ampicillin, Cephalothin, Cefoxitin, Sulfisoxazole, | 23% isolates produce ESBL. The isolates include | |
| 7 | T. Asfaw et al 2017 | Erythromycin, Gentamycin, Amikacin, Amoxicillin-Clavulanic acid, Ceftriaxone, Ciprofloxacin, Tetracycline, Cotrimoxazole, Ampicillin, Penicillin, Chloramphenicol, Doxycycline and Cefoxitin | Overall MDR prevalence from final effluents was 84%. Among isolates, 28.6% were resistant to for six and more antibiotics. One isolates of |